Vifor appoints Dario Eklund head of international business and Abdul Mullick head of global marketing

Swiss-based iron deficiency specialist Vifor Pharma has appointed Dario Eklund as head of international business operations, and Abdul Mullick as head of global marketing, at its headquarters in Zurich.

Mr Eklund joins Vifor from Organogenesis in Boston, where he was vice president responsible for non-US operations, business development and licensing. Before this, he was general manager of Aventis Pharma (now Sanofi), which he joined from various roles at Novartis.

Mr Mullick joins the company from Sanofi in Boston where he was vice president and general manager of endocrinology and cardiology in the rare diseases division. Prior to this, he was responsible for global marketing for rare genetic diseases. He has also spent several years with Genzyme in Europe, where he was head of the endocrine and renal business unit for the Asia-Pacific region and the endocrine unit in Europe. Before Genzyme, he also held positions at Novartis.